Clinical Trials

Study Title:
An Open-Label, Multicenter, Phase 1/2 Study of RP1 as a Single Agent and in Combination with PD1 Blockade in Patients with Solid Tumors (IGNYTE)

For more information about the trial above please contact the study team:

Principal Investigator, John Kaczmar, at kaczmar@musc.edu, or please call +1 843-792-6691.

Study Coordinator, Kristina Godwin, at woodrufk@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina